Tivozanib in Combination With Paclitaxel in Patients With Locally Recurrent or Metastatic Triple Negative Breast Cancer

NCT01745367 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

30

Enrollment

INDUSTRY

Sponsor class

Stopped low enrollment

Conditions

Triple Negative Breast Cancer

Interventions

DRUG: Tivozanib Hydrochloride
DRUG: paclitaxel
DRUG: Placebo

Sponsor

AVEO Pharmaceuticals, Inc.

Collaborators

[object Object]